Skip to main content
Clinical Trials/NCT06150300
NCT06150300
Not yet recruiting
Not Applicable

STAPLE (Severe asThmA PuLmonary rEhab): Examining the Effects of a Remote Pulmonary Rehabilitation Program in the Severe Asthma Population.

University of Saskatchewan0 sites34 target enrollmentJanuary 1, 2024
ConditionsAsthma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Asthma
Sponsor
University of Saskatchewan
Enrollment
34
Primary Endpoint
CPET
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

This is a randomized control trial evaluating the effect of a novel mobile application-delivered pulmonary rehabilitation program in adult severe asthma patients. The intervention will include eight weeks of exercise videos that progress in difficulty, as well as asthma-specific educational content. The primary outcome measure is change in functional exercise capacity as measured by six-minute walk distance. Secondary outcome measures will include evaluation of overall feasibility, and change in CPET parameters such as VO2max. Change in asthma control questionnaire (ACQ), asthma quality of life questionnaire (AQLQ) and PRAISE self-efficacy score will also be evaluated.

Registry
clinicaltrials.gov
Start Date
January 1, 2024
End Date
December 31, 2026
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Brianne Philipenko

Assistant Professor, MD FRCPC

University of Saskatchewan

Eligibility Criteria

Inclusion Criteria

  • Adults aged 18 years and older with a diagnosis of asthma by a respirologist. They must have severe disease defined by GINA severity classification. Participants must have access to a smartphone or internet browser to allow access to study content.

Exclusion Criteria

  • Exclusion criteria include comorbid cardiopulmonary or musculoskeletal conditions that may impact exercise tolerance in accordance with the American Thoracic Society CPET guidelines

Outcomes

Primary Outcomes

CPET

Time Frame: After 8 weeks of intervention

VO2max

Similar Trials